Gilead Sciences Acquires Tubulis in 315 Billion Deal to Strengthen Oncology Pipeline IPO Market Primer Key Steps and Considerations for Companies Going Public Tech Media Telecom Roundup Market Talks Highlight DeepSeek SoFi and Sector Developments IBR vs RAP Federal Student Loan Repayment Options Compared UK Spy Chief Warns Western Allies Face Moment of Consequence as RussiaChina Threats Mount SpaceX Scrubs Starship Test Flight Targets Friday for Debut of Upgraded V3 Rocket eBay Q1 2026 Earnings EPS Beats Estimates as Stock Declines Amid Revenue Uncertainties LUMN Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Restructuring Challenges Persist PLX Q1 2026 Earnings Massive EPS Surprise Drives Stock Higher Sprouts Farmers Market SFM Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher PPTA Q1 2026 Earnings Widening Losses Amid StantecFinanced Stibnite Gold Project Progress FONR Q1 2025 Earnings Profitability Maintained Amid Limited Disclosure XCHG Limited XCH Rebounds From Key Support Resistance Test Ahead BP Shares Decline Over 2 as Energy Sector Faces Headwinds Support Levels in Focus Enova International ENVA Declines 175 as Stock Holds Between Key Support and Resistance Elicio Therapeutics ELTX Holds Near Resistance as Therapeutic Pipeline Momentum Builds Atmus Filtration Technologies ATMU Edges Higher in LowVolume Session Testing Key Technical Zone Bank of America Predicts Fed Rate Cuts Unlikely Before Second Half of 2027 TNXP Q1 2026 Earnings WiderthanExpected Loss Amid Continued RD Investment HCA Healthcare Edges Higher on Steady Hospital Demand and Sector Resilience HCA Karbon Capital Partners Warrant KBONW Surges 2069 Momentum Builds Toward Resistance Nakamoto Inc NAKA Surges 915 Breaking Above Key Resistance Levels Milestone Scientific MLSS Rallies 39 as Shares Approach Key Resistance at 042 Sotherly Hotels Preferred Stock SOHOB Plunges Over 8 as Support Levels Tested Perdoceo Education PRDO Maintains Stability Near 34 Amid Modest Gains Trinity Capital 7875 Notes TRINI Edge Higher in Modest Trading Amid Steady Yield Appeal Calidi Biotherapeutics CLDI Slides 366 as Shares Test Support Levels